Yungjin Pharm Co Ltd (003520) — Cash Flow Reinvestment Rate
Yungjin Pharm Co Ltd (003520) has a Cash Flow Reinvestment Rate of 0.61x as of September 2025, reinvesting ₩4.28 Billion (capex ₩2.16 Billion plus investments ₩-2.12 Billion) from operating cash flow of ₩7.00 Billion. Explore Yungjin Pharm Co Ltd capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Yungjin Pharm Co Ltd Cash Flow Reinvestment Rate (2013–2024)
Historical reinvestment intensity for Yungjin Pharm Co Ltd across 10 annual periods. Also explore 003520 current and non-current assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Yungjin Pharm Co Ltd (2013–2024)
Year-by-year capital reinvestment analysis for Yungjin Pharm Co Ltd. For live market cap and broader valuation context, see Yungjin Pharm Co Ltd market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.13x | ₩24.61 Billion | ₩21.74 Billion | ₩21.61 Billion | ▼ -19.9% |
| 2021 | 1.41x | ₩11.82 Billion | ₩8.37 Billion | ₩11.32 Billion | ▲ +71.3% |
| 2020 | 0.82x | ₩11.96 Billion | ₩14.50 Billion | ₩6.30 Billion | ▼ -63.0% |
| 2019 | 2.23x | ₩20.69 Billion | ₩9.28 Billion | ₩10.36 Billion | ▼ -61.3% |
| 2018 | 5.76x | ₩7.34 Billion | ₩1.27 Billion | ₩4.71 Billion | ▲ +9.4% |
| 2017 | 5.26x | ₩16.59 Billion | ₩3.15 Billion | ₩10.59 Billion | ▲ +240.9% |
| 2016 | 1.54x | ₩4.81 Billion | ₩3.11 Billion | ₩4.69 Billion | ▼ -10.4% |
| 2015 | 1.72x | ₩15.16 Billion | ₩8.80 Billion | ₩13.75 Billion | ▼ -6.1% |
| 2014 | 1.84x | ₩11.41 Billion | ₩6.22 Billion | ₩11.30 Billion | ▲ +38.1% |
| 2013 | 1.33x | ₩7.91 Billion | ₩5.95 Billion | ₩6.63 Billion | — |